• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Peer To Peer Network
Salazar Resources Ltd Ord
SuperCom, Ltd. - Ordinary Shares
Edit Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eliem Therapeutics, Inc - Common Stock (NQ:ELYM)

5.110 UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Eliem Therapeutics, Inc - Common Stock

News headline image
Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc.
October 02, 2024
From Eliem Therapeutics, Inc.
Via GlobeNewswire
News headline image
Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit
September 11, 2024
From Eliem Therapeutics, Inc.
Via GlobeNewswire
News headline image
Eliem Therapeutics Announces Additions to its Leadership Team
August 26, 2024
From Eliem Therapeutics, Inc.
Via GlobeNewswire
News headline image
Eliem Therapeutics Reports Second Quarter Financial Results
August 14, 2024
From Eliem Therapeutics, Inc.
Via GlobeNewswire
News headline image
Eliem Therapeutics Announces its Addition to the Russell 2000® and Russell 3000® Indexes
June 28, 2024
From Eliem Therapeutics, Inc.
Via GlobeNewswire
News headline image
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
June 27, 2024
From Eliem Therapeutics, Inc.
Via GlobeNewswire
News headline image
ELYM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Eliem Therapeutics, Inc. Is Fair to Shareholders
April 11, 2024
From Halper Sadeh LLC
Via Business Wire
News headline image
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
April 11, 2024
From Eliem Therapeutics, Inc.
Via GlobeNewswire
News headline image
Eliem Therapeutics Announces Plans to Explore Strategic Alternatives
July 20, 2023
From Eliem Therapeutics, Inc.
Via GlobeNewswire
News headline image
Eliem Therapeutics Reports First Quarter Financial Results and Business Highlights
May 11, 2023
From Eliem Therapeutics, Inc.
Via GlobeNewswire
News headline image
Eliem Therapeutics Reports Fourth Quarter and Year-End Financial Results and Business Highlights
March 06, 2023
From Eliem Therapeutics, Inc.
Via GlobeNewswire
News headline image
Eliem Therapeutics Provides Strategic Update and Announces Leadership Transition
February 09, 2023
From Eliem Therapeutics, Inc.
Via GlobeNewswire
News headline image
Eliem Therapeutics at the 5th Annual Evercore ISI HealthCONx Virtual Conference
November 30, 2022
From Eliem Therapeutics, Inc.
Via GlobeNewswire
News headline image
Eliem Therapeutics Reports Third Quarter Financial and Business Highlights
November 14, 2022
From Eliem Therapeutics, Inc.
Via GlobeNewswire
News headline image
Eliem Therapeutics to Participate at Two Upcoming Investor Conferences
November 08, 2022
From Eliem Therapeutics, Inc.
Via GlobeNewswire
News headline image
Eliem Therapeutics Provides Update on Pipeline Progress
October 05, 2022
From Eliem Therapeutics, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap